BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 28, 2012
View Archived Issues
CAP-7.1 evaluated in patients with solid tumors
Read More
Sarepta Therapeutics enters collaboration for DMD drug
Read More
miRNA-768-3p is downregulated in human GBM cells
Read More
Autophagy-related proteins correlate with acute myelogenous leukemia prognosis
Read More
Lilly Japan set to launch Zyprexa intramuscular injection
Read More
EMA accepts for review MAAs for vintafolide and etarfolatide
Read More
Novel IL-4/IL-13 binding proteins patented by Janssen Biotech and Molecular Partners
Read More
Unigene and Tarix enter licensing agreement for TXA-127
Read More
FDA clears Avaxia Biologics' IND for AVX-470
Read More
Amakem patents new ROCK-II inhibitors
Read More
ChemoCentryx begins phase I trial of CCX-872
Read More
Panacela Labs signs contract with Russian Ministry of Industry and Trade
Read More
Novel agents for the treatment of myocardial infarction disclosed by Grindeks
Read More
MMRF partners with the Department of Veterans Affairs
Read More
Gilead Sciences reports results from phase III sofosbuvir trial
Read More
Johns Hopkins researchers develop pan-malaria transmission-blocking vaccine
Read More
Phase III pimavanserin study meets primary endpoints
Read More
Japanese scientists present new humanized monoclonal antibodies
Read More
Ruga presents next-generation B-raf V600E inhibitors
Read More
Amgen synthesizes novel protein kinase inhibitors
Read More
Phase II study of ProHema for hematologic malignancies begins
Read More
U.K.'s NICE selects ThromboGenics' Jetrea for single technology appraisal
Read More
Trial of Bayer's investigational hemophilia treatment completes recruitment of first cohort
Read More
European Commission approves Viread for two new indications
Read More
Forest Laboratories submits NDA for cariprazine in two mental health disorders
Read More
Almirall reports novel PI3Kdelta inhibitors
Read More